IL1B and diabetes mellitus: In diabetes, persistent hyperglycemia leads to “a state of chronic low-grade inflammation, characterized by elevated levels of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and IL-6.